Clinical trials
Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in India
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 2 |
| 2022 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Columbia University | 2 |
| National Institutes of Health Clinical Center (CC) | 2 |
| Pfizer | 2 |
| University of Geneva, Switzerland | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 7 |
| Leukemia | 3 |
| Burkitt Lymphoma | 2 |
| Genetic Predisposition to Disease | 2 |
| Congenital Microtia | 1 |
| Dendritic Cell Sarcoma, Interdigitating | 1 |
| Drug-Related Side Effects and Adverse Reactions | 1 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 |
| Lymphoma | 1 |
| Lymphoma, B-Cell, Marginal Zone | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.